Viking Therapeutics, Inc

(NASDAQ:VKTX)

Latest On Viking Therapeutics, Inc (VKTX):

Date/Time Type Description Signal Details
2023-05-31 11:44 ESTNewsViking Therapeutics a buy at Roth on NASH candidate and pipelineN/A
2023-05-17 23:12 ESTNewsViking Therapeutics: Latest NASH Data Reinforces Drive Towards Finish LineN/A
2023-05-16 20:05 ESTNewsViking stock rises after drug helps reduce liver fat, meets mid-stage study goalN/A
2023-05-16 20:05 ESTNewsHot Stocks: SE and IQ slip after earnings; HZNP down on FTC lawsuit; VOD fall on job cuts; AMD and VKTX gainN/A
2023-05-02 15:34 ESTNewsViking Therapeutics off 5% following CEO stock saleN/A
2023-04-26 23:05 ESTNewsViking Therapeutics GAAP EPS of -$0.25 misses by $0.01N/A
2023-04-26 23:04 ESTNewsViking Therapeutics, Inc. (VKTX) Q1 2023 - Earnings Call TranscriptN/A
2023-04-25 22:45 ESTNewsViking Therapeutics Q1 2023 Earnings PreviewN/A
2023-04-04 22:00 ESTNewsViking Therapeutics: A Promising NASH Diversification PlayN/A
2023-03-30 16:49 ESTNewsViking Therapeutics sheds on pricing $250M stock offeringN/A
2023-03-29 19:41 ESTNewsViking Therapeutics proposes stock offering, size not disclosedN/A
2023-03-29 04:24 ESTNewsWhy did Viking Therapeutics stock soar today? Obesity drug dataN/A
2023-03-28 13:22 ESTNewsViking jumps 39% on early-stage data for obesity candidateN/A
2023-03-28 13:21 ESTNewsHot Stocks: PVH rises on earnings; OXY up on BRK.A stake boost; PARA and CIEN analyst upgrades; VKTX gains; FUTU and LYFT slidesN/A
2023-03-17 00:45 ESTNewsViking Therapeutics: Some Caution WarrantedN/A
2023-02-09 17:02 ESTNewsViking hits multi-year high after Q4 2022 earnings updateN/A
2023-02-09 03:11 ESTNewsViking Therapeutics GAAP EPS of -$0.26 misses by $0.03N/A
2023-02-09 03:11 ESTNewsViking Therapeutics, Inc. (VKTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-08 00:47 ESTNewsViking Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-03 21:58 ESTNewsViking Therapeutics: Booking Profits Following NASH Sympathy MoveN/A
2023-01-03 08:01 ESTNewsViking Therapeutics sues Ascletis Pharma for stealing trade secretsN/A
2022-12-15 00:25 ESTNewsViking Therapeutics: Potential To Embolden Itself In NASH SpaceN/A
2022-10-27 00:15 ESTNewsViking Therapeutics GAAP EPS of -$0.21 beats by $0.02N/A
2022-10-27 00:14 ESTNewsViking Therapeutics, Inc. (VKTX) Q3 2022 Earnings Call TranscriptN/A
2022-08-30 11:34 ESTNewsViking Therapeutics: Playing Second Fiddle To MadrigalN/A
2022-07-28 01:19 ESTNewsViking Therapeutics GAAP EPS of -$0.23 misses by $0.02N/A
2022-07-28 01:19 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q2 2022 Results - Earnings Call TranscriptN/A
2022-07-26 22:20 ESTNewsViking Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-19 23:41 ESTNewsFDA lifts clinical hold on Viking's phase 1b trial of its genetic disorder X-ALD treatmentN/A
2022-06-07 03:37 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-04-28 04:50 ESTNewsViking Therapeutics GAAP EPS of -$0.21 misses by $0.02N/A
2022-04-28 04:50 ESTNewsViking Therapeutics' (VKTX) CEO Brian Lian on Q1 2022 Results - Earnings CallN/A
2022-04-26 22:04 ESTNewsViking Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-20 20:04 ESTNewsRevisiting Viking TherapeuticsN/A
2022-02-10 17:26 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q4 2021 Results - Earnings CallN/A
2022-02-10 17:25 ESTNewsViking Therapeutics rises 8% following Q4 resultsN/A
2022-02-09 20:23 ESTNewsViking Therapeutics GAAP EPS of -$0.16 beats by $0.03N/A
2022-02-09 02:23 ESTNewsViking Therapeutics Q4 2021 Earnings PreviewN/A
2022-01-24 11:52 ESTNewsFDA puts clinical hold on Viking Therapeutics' Phase 1b trial of VK0214 in X-ALDN/A
2021-11-04 18:23 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 21:02 ESTNewsViking Therapeutics EPS beats by $0.04N/A
2021-11-03 01:23 ESTNewsViking Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-22 09:53 ESTNewsViking Therapeutics (VKTX) Investor Presentation - SlideshowN/A
2021-09-22 09:35 ESTNewsViking Therapeutics (VKTX) Investor Prensentation - SlideshowN/A
2021-08-27 17:52 ESTNewsViking Therapeutics: Remaining Bullish And Sticking To My PlanN/A
2021-07-30 03:27 ESTNews89bio and Viking Therapeutics become BTIG’s top picks in NASH spaceN/A
2021-07-29 06:42 ESTNewsViking Therapeutics shares fall after wider Q2 net lossN/A
2021-07-29 06:42 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 07:17 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 06:59 ESTNewsViking Therapeutics gain 4% premarket as director buys over $113K worthN/A

About Viking Therapeutics, Inc (VKTX):

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

VKTX Quotes by TradingView

See Advanced Chart

General

  • Name Viking Therapeutics, Inc
  • Symbol VKTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 18
  • Fiscal Year EndDecember
  • IPO Date2015-04-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.vikingtherapeutics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.04
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.79
  • Next Year EPS Estimate -$1.03
  • Next Quarter EPS Estimate -$0.17
  • Return on Assets -10%
  • Return on Equity -15%
  • Earnings Per Share -$0.35
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 484.09 million
  • PEG Ratio -0.03
  • Analyst Target Price $19.71
  • Book Value Per Share $3.34
View More

Share Statistics

  • Shares Outstanding 74.13 million
  • Shares Float 57.78 million
  • % Held by Insiders 1051%
  • % Held by Institutions 56.71%
  • Shares Short 8.42 million
  • Shares Short Prior Month 8.28 million
  • Short Ratio 4.35
  • Short % of Float 15%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta 1.74
  • 52 Week High $10.09
  • 52 Week Low $3.85
  • 50 Day Moving Average 7.49
  • 200 Day Moving Average 6.51
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Viking Therapeutics, Inc (VKTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Viking Therapeutics, Inc (VKTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-17$N/A-$0.15-$0.151.77%
2020-09-302020-10-28$N/A-$0.13-$0.1513.33%
2020-06-302020-07-29$N/A-$0.13-$0.149.91%
2020-03-312020-04-30$N/A-$0.13-$0.12-6.73%
2019-12-312020-02-26$N/A-$0.10-$0.1322.06%
2019-09-302019-11-05$N/A-$0.08-$0.1336.41%
2019-06-302019-08-01$N/A-$0.11-$0.09-24.58%
2019-03-312019-05-02$N/A-$0.07-$0.0918.22%
2018-12-312019-03-13$N/A-$0.07-$0.1031.37%
2018-09-302018-11-07$N/A-$0.11-$0.126.38%
2018-06-302018-08-09$N/A-$0.13-$0.11-16.8%
2018-03-312018-05-09$N/A-$0.08-$0.1234.43%
2017-12-312018-03-07$N/A-$0.14-$0.1821.35%
2017-09-302017-11-08$N/A-$0.22-$0.20-11.85%
2017-06-302017-08-09$N/A-$0.21-$0.19-12%
2017-03-312017-05-10$N/A-$0.23-$0.17-33.33%
2016-12-312017-03-21$N/A-$0.18-$0.2114.29%
2016-09-302016-11-10$N/A-$0.20-$0.229.91%
2016-06-302016-08-10$N/A-$0.22-$0.22-1.15%
2016-03-312016-05-10$N/A-$0.40-$0.4511.11%
2015-12-312016-03-08$N/A-$0.56-$0.46-21.74%
2015-09-302015-11-05$N/A-$0.53-$0.32-65.63%
2015-06-302015-08-13$N/A-$1.07-$0.13-723.08%
2015-03-312015-06-11$N/A-$1.40$0.28-600%

Viking Therapeutics, Inc (VKTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Viking Therapeutics, Inc (VKTX) Chart:

Viking Therapeutics, Inc (VKTX) News:

Below you will find a list of latest news for Viking Therapeutics, Inc (VKTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Viking Therapeutics, Inc (VKTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-10-161518.45CALL3 354.88TRUE18.450
2026-10-1617.50CALL0 5893.35TRUE00
2026-10-162014CALL2 17195.77TRUE140
2026-10-1622.50CALL0 18389.16TRUE00
2026-10-16250CALL0 17792.4TRUE00
2026-10-1627.50CALL0 1388.25TRUE00
2026-10-16307.13CALL0 34891.13TRUE00
2026-10-1632.55.85CALL0 21581.11TRUE00
2026-10-16354.7CALL35 67188.13FALSE-0.02-0
2026-10-1637.54CALL32 13189.84FALSE00
2026-10-16403.37CALL10 252491.61FALSE0.070.02
2026-10-1642.52.77CALL5 107290.15FALSE00
2026-10-16452.55CALL1 236592.12FALSE0.220.09
2026-10-1647.52.13CALL2175 1649499.34FALSE0.190.1
2026-10-16501.64CALL22 62598.35FALSE-0.06-0.04
2026-10-16550CALL0 976102.08FALSE00
2026-10-16601CALL14 658103.99FALSE0.010.01
2026-10-16150PUT0 0131.36FALSE00
2026-10-1617.50.31PUT0 21109.76FALSE00
2026-10-16200.54PUT2 6100.11FALSE0.540
2026-10-1622.50.98PUT277 58993.54FALSE-0.03-0.03
2026-10-16251.7PUT5 512092.58FALSE0.090.06
2026-10-1627.50PUT0 4499.48FALSE00
2026-10-16303.65PUT0 20294.76FALSE00
2026-10-1632.50PUT0 5488.22FALSE00
2026-10-16356.2PUT13 20192.22TRUE-0.3-0.05
2026-10-1637.50PUT0 44194.1TRUE00
2026-10-16400PUT0 7394.39TRUE00
2026-10-1642.511.48PUT35 1093.38TRUE11.480
2026-10-16450PUT0 493.08TRUE00
2026-10-1647.50PUT0 0102.48TRUE00
2026-10-16500PUT0 0104.62TRUE00
2026-10-16550PUT0 0108.12TRUE00
2026-10-16600PUT0 1104.38TRUE00
2026-11-20150CALL0 098.73TRUE00
2026-11-2017.50CALL0 3100.41TRUE00
2026-11-20200CALL0 9393.78TRUE00
2026-11-2022.50CALL0 090.02TRUE00
2026-11-20250CALL0 3991.46TRUE00
2026-11-2027.50CALL0 590.56TRUE00
2026-11-20308.5CALL4 7192.91TRUE0.50.06
2026-11-2032.56.8CALL0 10689.59TRUE00
2026-11-20355.79CALL0 27189.7FALSE00
2026-11-2037.54.99CALL0 6690.66FALSE00
2026-11-20404.3CALL2 25393.05FALSE-0.19-0.04
2026-11-2042.53.7CALL0 14091.91FALSE00
2026-11-20453.3CALL53 22988.21FALSE00
2026-11-2047.52.97CALL1 3892.67FALSE2.970
2026-11-20502.77CALL261 235996.16FALSE0.170.07
2026-11-20550CALL0 12586.52FALSE00
2026-11-20601.5CALL2 25795.23FALSE1.50
2026-11-20150PUT0 15108.17FALSE00
2026-11-2017.50PUT0 1097.15FALSE00
2026-11-20201PUT310 3998.29FALSE00
2026-11-2022.51.5PUT61 43391.64FALSE-0.2-0.12
2026-11-20250PUT0 5796.22FALSE00
2026-11-2027.50PUT0 2497.06FALSE00
2026-11-20304.41PUT50 30791.35FALSE-0.09-0.02
2026-11-2032.55.6PUT3 1694.99FALSE5.60
2026-11-20357.03PUT1 12489.2TRUE7.030
2026-11-2037.50PUT0 1191.79TRUE00
2026-11-20400PUT0 3493.71TRUE00
2026-11-2042.512.25PUT1 093.84TRUE12.250
2026-11-20450PUT0 2291.91TRUE00
2026-11-2047.50PUT0 596.97TRUE00
2026-11-20500PUT0 12587.73TRUE00
2026-11-20550PUT0 098.21TRUE00
2026-11-20600PUT0 098.65TRUE00
2027-01-1512.50CALL0 290109.42TRUE00
2027-01-15150CALL0 130696.2TRUE00
2027-01-1517.50CALL0 7291.38TRUE00
2027-01-15200CALL0 75197.8TRUE00
2027-01-1522.50CALL0 31388.45TRUE00
2027-01-152511.95CALL57 125391.32TRUE0.190.02
2027-01-1527.50CALL0 44288.53TRUE00
2027-01-15309.67CALL1 558495.52TRUE0.670.07
2027-01-1532.57.9CALL0 44086.8TRUE00
2027-01-15357.2CALL104 195086.11FALSE0.20.03
2027-01-1537.56.52CALL2 98986.14FALSE6.520
2027-01-15405.48CALL0 524687.81FALSE00
2027-01-1542.54.85CALL7 51082.01FALSE4.850
2027-01-15450CALL0 273987.7FALSE00
2027-01-1547.50CALL0 13078.95FALSE00
2027-01-15503.5CALL24 1099991.4FALSE0.20.06
2027-01-1552.50CALL0 29378.55FALSE00
2027-01-15552.65CALL0 235386.72FALSE00
2027-01-1557.50CALL0 24486.39FALSE00
2027-01-15602.2CALL1 290187.21FALSE0.020.01
2027-01-1562.50CALL0 21688.67FALSE00
2027-01-15650CALL0 84189.46FALSE00
2027-01-1567.50CALL0 7489.14FALSE00
2027-01-15701.38CALL7 99288.15FALSE00
2027-01-1572.50CALL0 4280.08FALSE00
2027-01-15751.11CALL2 421585.24FALSE0.020.02
2027-01-1577.50CALL0 1583.68FALSE00
2027-01-15800.9CALL1 633688.76FALSE0.010.01
2027-01-1582.50CALL0 70182.9FALSE00
2027-01-15850CALL0 63291.17FALSE00
2027-01-15900.71CALL1 327292.75FALSE0.710
2027-01-15950CALL0 60296.17FALSE00
2027-01-151000.5CALL15 889488.45FALSE-0.04-0.07
2027-01-151050CALL0 19991.01FALSE00
2027-01-151100CALL0 287100.77FALSE00
2027-01-151150CALL0 7498.05FALSE00
2027-01-151200.3CALL6 844990.21FALSE-0.02-0.06
2027-01-1512.50PUT0 140112.4FALSE00
2027-01-15150PUT0 205101.47FALSE00
2027-01-1517.50PUT0 15093.94FALSE00
2027-01-15201.54PUT0 65489.79FALSE00
2027-01-1522.52.2PUT1 57887.06FALSE2.20
2027-01-15250PUT0 86288.05FALSE00
2027-01-1527.54.23PUT0 32787.5FALSE00
2027-01-15305.35PUT0 75986.69FALSE00
2027-01-1532.56.82PUT0 19286.68FALSE00
2027-01-15350PUT0 40986.33TRUE00
2027-01-1537.59.75PUT7 13189.76TRUE9.750
2027-01-15400PUT0 37084.4TRUE00
2027-01-1542.50PUT0 8884.45TRUE00
2027-01-15450PUT0 6085.85TRUE00
2027-01-1547.50PUT0 3084.37TRUE00
2027-01-155019.5PUT0 65083.84TRUE00
2027-01-1552.50PUT0 1088.27TRUE00
2027-01-155523.8PUT0 58189.41TRUE00
2027-01-1557.50PUT0 3889.05TRUE00
2027-01-15600PUT0 11491TRUE00
2027-01-1562.50PUT0 5491.5TRUE00
2027-01-15650PUT0 14792.32TRUE00
2027-01-1567.50PUT0 086.7TRUE00
2027-01-15700PUT0 3986.86TRUE00
2027-01-1572.50PUT0 386.61TRUE00
2027-01-15750PUT0 3987.03TRUE00
2027-01-1577.50PUT0 5486.34TRUE00
2027-01-15800PUT0 103392.85TRUE00
2027-01-1582.50PUT0 187.34TRUE00
2027-01-15850PUT0 31586.71TRUE00
2027-01-15900PUT0 0101.58TRUE00
2027-01-15950PUT0 099.11TRUE00
2027-01-151000PUT0 090.99TRUE00
2027-01-151050PUT0 0103.85TRUE00
2027-01-151100PUT0 0107.39TRUE00
2027-01-151150PUT0 14112.77TRUE00
2027-01-151200PUT0 50116.01TRUE00
2027-02-19150CALL0 489.83TRUE00
2027-02-1917.50CALL0 191.08TRUE00
2027-02-19200CALL0 1090TRUE00
2027-02-1922.50CALL0 387.87TRUE00
2027-02-19250CALL0 1985.5TRUE00
2027-02-1927.50CALL0 089.34TRUE00
2027-02-19300CALL0 3390.36TRUE00
2027-02-1932.50CALL0 588.8TRUE00
2027-02-19358CALL0 4285.16FALSE00
2027-02-1937.50CALL0 1787.37FALSE00
2027-02-19400CALL0 5387.81FALSE00
2027-02-1942.50CALL0 1085.14FALSE00
2027-02-19450CALL0 8086.82FALSE00
2027-02-1947.54.67CALL1 182.67FALSE4.670
2027-02-19500CALL0 1683FALSE00
2027-02-19550CALL0 4286.95FALSE00
2027-02-19600CALL0 092.29FALSE00
2027-02-19150PUT0 095.91FALSE00
2027-02-1917.50PUT0 093.3FALSE00
2027-02-19200PUT0 1192.4FALSE00
2027-02-1922.52.73PUT29 491.04FALSE2.730
2027-02-19250PUT0 283.56FALSE00
2027-02-1927.50PUT0 185.05FALSE00
2027-02-19300PUT0 4288.9FALSE00
2027-02-1932.50PUT0 187.04FALSE00
2027-02-19350PUT0 1189.15TRUE00
2027-02-1937.50PUT0 088TRUE00
2027-02-19400PUT0 1188.25TRUE00
2027-02-1942.50PUT0 085.87TRUE00
2027-02-19450PUT0 087.07TRUE00
2027-02-1947.50PUT0 084.18TRUE00
2027-02-19500PUT0 085.1TRUE00
2027-02-19550PUT0 086.43TRUE00
2027-02-19600PUT0 082.63TRUE00
2027-12-171522.55CALL0 506111.24TRUE00
2027-12-1717.50CALL0 44110.72TRUE00
2027-12-172020.54CALL3 190109.7TRUE20.540
2027-12-1722.50CALL0 24106.36TRUE00
2027-12-17250CALL0 437104TRUE00
2027-12-1727.50CALL0 19105.34TRUE00
2027-12-173017.95CALL2 461106.4TRUE17.950
2027-12-1732.516.63CALL1 41109.16TRUE0.820.05
2027-12-173515.88CALL1 674104.65FALSE0.630.04
2027-12-1737.514.7CALL1 91102.4FALSE14.70
2027-12-174014.36CALL2 2718104.34FALSE14.360
2027-12-1742.513.59CALL0 68105.03FALSE00
2027-12-17450CALL0 103103.02FALSE00
2027-12-1747.50CALL0 21105.49FALSE00
2027-12-175012.1CALL1 553105.66FALSE12.10
2027-12-17550CALL0 252103.69FALSE00
2027-12-176011CALL6 9289109.53FALSE0.370.03
2027-12-17150PUT0 83105.64FALSE00
2027-12-1717.50PUT0 156105.34FALSE00
2027-12-17206PUT0 110103.38FALSE00
2027-12-1722.50PUT0 18102.07FALSE00
2027-12-17250PUT0 103101.55FALSE00
2027-12-1727.50PUT0 11102.16FALSE00
2027-12-173011.6PUT34 302101.92FALSE11.60
2027-12-1732.50PUT0 17103.38FALSE00
2027-12-17350PUT0 33103.35TRUE00
2027-12-1737.50PUT0 23103.33TRUE00
2027-12-17400PUT0 39102.98TRUE00
2027-12-1742.50PUT0 1399.56TRUE00
2027-12-17450PUT0 2098.94TRUE00
2027-12-1747.50PUT0 0103.16TRUE00
2027-12-17500PUT0 35102.55TRUE00
2027-12-17550PUT0 1104.56TRUE00
2027-12-17600PUT0 199101.65TRUE00
2028-01-2112.525CALL0 250116.69TRUE00
2028-01-21150CALL0 163112.25TRUE00
2028-01-2117.50CALL0 75112.36TRUE00
2028-01-21200CALL0 167110.76TRUE00
2028-01-2122.50CALL0 57105.78TRUE00
2028-01-21250CALL0 115107.46TRUE00
2028-01-2127.50CALL0 109106.12TRUE00
2028-01-213017.2CALL12 1208104.64TRUE00
2028-01-2132.516.3CALL0 129108.65TRUE00
2028-01-213516.52CALL8 780106.2FALSE0.570.04
2028-01-2137.516.5CALL1 139107.89FALSE1.420.09
2028-01-214014.55CALL13 2317105.42FALSE0.560.04
2028-01-2142.50CALL0 54103.72FALSE00
2028-01-214513.83CALL5 630103.75FALSE13.830
2028-01-2147.50CALL0 98104.41FALSE00
2028-01-215012.73CALL5 655105.87FALSE12.730
2028-01-21550CALL0 126107.09FALSE00
2028-01-216011.97CALL66 6732108.86FALSE0.770.07
2028-01-2112.50PUT0 37102.92FALSE00
2028-01-21153.88PUT1 4599.18FALSE3.880
2028-01-2117.50PUT0 212104.35FALSE00
2028-01-21200PUT0 178104.97FALSE00
2028-01-2122.50PUT0 13104.02FALSE00
2028-01-21250PUT0 91103.38FALSE00
2028-01-2127.50PUT0 633103.27FALSE00
2028-01-213012PUT0 83103.44FALSE00
2028-01-2132.50PUT0 38103.53FALSE00
2028-01-21350PUT0 145103.41TRUE00
2028-01-2137.50PUT0 20102.95TRUE00
2028-01-21400PUT0 181102.38TRUE00
2028-01-2142.50PUT0 799.02TRUE00
2028-01-21450PUT0 2199.23TRUE00
2028-01-2147.50PUT0 099.37TRUE00
2028-01-21500PUT0 89100.42TRUE00
2028-01-21550PUT0 26101.93TRUE00
2028-01-21600PUT0 220101.22TRUE00

Latest VKTX Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST100$2.125
Jun 13, 2022 7:58 PM EST100$2.125
Jun 13, 2022 7:58 PM EST38$2.125
Jun 13, 2022 7:59 PM EST90$2.13
Jun 13, 2022 7:59 PM EST100$2.13

Viking Therapeutics, Inc (VKTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120039521/0001209191-20-039521-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1607678/000000000018021941/0000000000-18-021941-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000009375119000115/0000093751-19-000115-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000009375119000378/0000093751-19-000378-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000009375120000478/0000093751-20-000478-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000021545719006859/0000215457-19-006859-index.htm
2018-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000031506618002427/0000315066-18-002427-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000031506619001442/0000315066-19-001442-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000031506620001268/0000315066-20-001268-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000083423720006932/0000834237-20-006932-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000089924318025453/0000899243-18-025453-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000089924320023546/0000899243-20-023546-index.htm
2020-08-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000089924320023644/0000899243-20-023644-index.htm
2018-06-07S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1607678/000095012318006165/0000950123-18-006165-index.htm
2018-07-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1607678/000095012318006751/0000950123-18-006751-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117266119000513/0001172661-19-000513-index.htm
2019-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117266119002034/0001172661-19-002034-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117266120000911/0001172661-20-000911-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117891319000440/0001178913-19-000440-index.htm
2018-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000119312518040234/0001193125-18-040234-index.htm
2018-11-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1607678/000119312518325600/0001193125-18-325600-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000119312519040832/0001193125-19-040832-index.htm
2020-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1607678/000119312520234860/0001193125-20-234860-index.htm
2018-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118028717/0001209191-18-028717-index.htm
2018-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118028718/0001209191-18-028718-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034482/0001209191-18-034482-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034485/0001209191-18-034485-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034490/0001209191-18-034490-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034494/0001209191-18-034494-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034496/0001209191-18-034496-index.htm
2018-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118041226/0001209191-18-041226-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118041236/0001209191-18-041236-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001558/0001209191-19-001558-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001561/0001209191-19-001561-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001563/0001209191-19-001563-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001564/0001209191-19-001564-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001566/0001209191-19-001566-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001568/0001209191-19-001568-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001571/0001209191-19-001571-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001575/0001209191-19-001575-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119004858/0001209191-19-004858-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119004861/0001209191-19-004861-index.htm
2019-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119040257/0001209191-19-040257-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119040272/0001209191-19-040272-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119044336/0001209191-19-044336-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119054654/0001209191-19-054654-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001418/0001209191-20-001418-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001419/0001209191-20-001419-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001420/0001209191-20-001420-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001421/0001209191-20-001421-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001422/0001209191-20-001422-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001425/0001209191-20-001425-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001426/0001209191-20-001426-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001428/0001209191-20-001428-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120004311/0001209191-20-004311-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120004314/0001209191-20-004314-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120023378/0001209191-20-023378-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120039521/0001209191-20-039521-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120050732/0001209191-20-050732-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120050734/0001209191-20-050734-index.htm
2018-02-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018001200/0001564590-18-001200-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018001242/0001564590-18-001242-index.htm
2018-02-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018001325/0001564590-18-001325-index.htm
2018-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018001404/0001564590-18-001404-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000156459018002076/0001564590-18-002076-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018004723/0001564590-18-004723-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1607678/000156459018004757/0001564590-18-004757-index.htm
2018-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1607678/000156459018004759/0001564590-18-004759-index.htm
2018-04-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1607678/000156459018007765/0001564590-18-007765-index.htm
2018-04-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459018007777/0001564590-18-007777-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018012440/0001564590-18-012440-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018012501/0001564590-18-012501-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018014719/0001564590-18-014719-index.htm
2018-06-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018015152/0001564590-18-015152-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018015228/0001564590-18-015228-index.htm
2018-06-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018015256/0001564590-18-015256-index.htm
2018-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018015450/0001564590-18-015450-index.htm
2018-07-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1607678/000156459018016919/0001564590-18-016919-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018021053/0001564590-18-021053-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018021125/0001564590-18-021125-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018023246/0001564590-18-023246-index.htm
2018-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018023312/0001564590-18-023312-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018023407/0001564590-18-023407-index.htm
2018-09-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018023464/0001564590-18-023464-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018028008/0001564590-18-028008-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018028101/0001564590-18-028101-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019007569/0001564590-19-007569-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1607678/000156459019007584/0001564590-19-007584-index.htm
2019-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1607678/000156459019007589/0001564590-19-007589-index.htm
2019-04-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1607678/000156459019010928/0001564590-19-010928-index.htm
2019-04-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459019010933/0001564590-19-010933-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019015327/0001564590-19-015327-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019015390/0001564590-19-015390-index.htm
2019-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019020346/0001564590-19-020346-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019024412/0001564590-19-024412-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019027983/0001564590-19-027983-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019028043/0001564590-19-028043-index.htm
2019-08-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019028058/0001564590-19-028058-index.htm
2019-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019028063/0001564590-19-028063-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019040059/0001564590-19-040059-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019040424/0001564590-19-040424-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1607678/000156459020006766/0001564590-20-006766-index.htm
2020-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1607678/000156459020006838/0001564590-20-006838-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020011413/0001564590-20-011413-index.htm
2020-04-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1607678/000156459020015522/0001564590-20-015522-index.htm
2020-04-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459020015533/0001564590-20-015533-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020020180/0001564590-20-020180-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459020020233/0001564590-20-020233-index.htm
2020-05-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459020026393/0001564590-20-026393-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020026582/0001564590-20-026582-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020034308/0001564590-20-034308-index.htm
2020-07-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459020034329/0001564590-20-034329-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020048337/0001564590-20-048337-index.htm
2020-10-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459020048398/0001564590-20-048398-index.htm
2018-07-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1607678/999999999518001837/9999999995-18-001837-index.htm
2020-02-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1607678/999999999720000814/9999999997-20-000814-index.htm

Viking Therapeutics, Inc (VKTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viking Therapeutics, Inc (VKTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1051%
Institutional Ownership: 5671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-07-01Hiroko MasamuneChief Development OfficerBuy15,000.00111,197.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118041236/0001209191-18-041236-index.htm
2019-01-03Hiroko MasamuneChief Development OfficerBuy22,667.00141,063.00https://www.sec.gov/Archives/edgar/data/1607678/000120919119001571/0001209191-19-001571-index.htm
2019-01-03Brian LianPresident & CEOBuy80,897.001,564,485.00https://www.sec.gov/Archives/edgar/data/1607678/000120919119001568/0001209191-19-001568-index.htm
2020-01-03Brian LianPresident & CEOBuy153,333.001,714,289.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120001426/0001209191-20-001426-index.htm
2020-09-15Brian LianPresident & CEOBuy55,500.001,761,555.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120050732/0001209191-20-050732-index.htm
2020-06-30MATTHEW W FOEHRDirectorSell13,000.007.3595,550.0026,250.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120039521/0001209191-20-039521-index.htm
2018-05-29Charles A Jr RowlandDirectorBuy30,000.005.16154,800.0030,000.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034490/0001209191-18-034490-index.htm
2018-05-29LAWSON MACARTNEYDirectorBuy47,965.005.22250,329.3447,965.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034482/0001209191-18-034482-index.htm
2020-08-26LIGAND PHARMACEUTICALS INC10% Share HolderSell94,488.008.11766,108.705,819,383.00https://www.sec.gov/Archives/edgar/data/1607678/000089924320023546/0000899243-20-023546-index.htm
2020-08-25LIGAND PHARMACEUTICALS INC10% Share HolderSell70,000.008.02561,575.005,968,083.00https://www.sec.gov/Archives/edgar/data/1607678/000089924320023546/0000899243-20-023546-index.htm
2018-09-25LIGAND PHARMACEUTICALS INC10% Share HolderSell262,881.0019.155,034,250.016,038,083.00https://www.sec.gov/Archives/edgar/data/1607678/000089924318025453/0000899243-18-025453-index.htm
2018-05-29Stephen W WebsterDirectorBuy8,000.005.2141,712.008,000.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034485/0001209191-18-034485-index.htm
2018-05-31MICHAEL MORNEAUVP, Finance and AdministrationSell21,551.009.25199,346.7594,035.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034494/0001209191-18-034494-index.htm
2018-05-31J MATTHEW SINGLETONDirectorBuy9,500.009.8293,260.559,500.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034496/0001209191-18-034496-index.htm
2020-09-15MICHAEL MORNEAUVP, Finance and AdministrationBuy4,500.0099,430.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120050734/0001209191-20-050734-index.htm